Literature DB >> 10480426

Neutrophil maturation and the role of retinoic acid.

N D Lawson1, N Berliner.   

Abstract

Neutrophil maturation occurs in well defined morphological stages that correlate with the acquisition of molecular markers associated with neutrophil function. A variety of factors are known to play a role in terminal neutrophil maturation, including the vitamin A derivative, retinoic acid. Retinoic acid can directly modulate gene expression via binding to its nuclear receptors, which can, in turn, activate transcription of target genes. A role for retinoic acid during neutrophil maturation has been suggested from a variety of sources. Here we present a review of the mechanism of retinoic acid receptor action and the major evidence showing that normal retinoid signaling is required for neutrophil maturation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10480426     DOI: 10.1016/s0301-472x(99)00085-5

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  18 in total

1.  Exploring the functional complexity of cellular proteins by protein knockout.

Authors:  Jianxuan Zhang; Ning Zheng; Pengbo Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-30       Impact factor: 11.205

2.  Regulation of cathelicidin gene expression: induction by lipopolysaccharide, interleukin-6, retinoic acid, and Salmonella enterica serovar typhimurium infection.

Authors:  H Wu; G Zhang; J E Minton; C R Ross; F Blecha
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 3.  Strategies to generate functionally normal neutrophils to reduce infection and infection-related mortality in cancer chemotherapy.

Authors:  Hisham Abdel-Azim; Weili Sun; Lingtao Wu
Journal:  Pharmacol Ther       Date:  2019-08-27       Impact factor: 12.310

4.  ROS-inhibitory activity of YopE is required for full virulence of Yersinia in mice.

Authors:  Warangkhana Songsungthong; Mary C Higgins; Hortensia G Rolán; Julia L Murphy; Joan Mecsas
Journal:  Cell Microbiol       Date:  2010-02-09       Impact factor: 3.715

5.  A myelopoiesis-associated regulatory intergenic noncoding RNA transcript within the human HOXA cluster.

Authors:  Xueqing Zhang; Zheng Lian; Carolyn Padden; Mark B Gerstein; Joel Rozowsky; Michael Snyder; Thomas R Gingeras; Philipp Kapranov; Sherman M Weissman; Peter E Newburger
Journal:  Blood       Date:  2009-01-14       Impact factor: 22.113

6.  Retinoic acid inhibits CD25+ dendritic cell expansion and γδ T-cell activation in experimental autoimmune uveitis.

Authors:  Dongchun Liang; Aijun Zuo; Hui Shao; Willi K Born; Rebecca L O'Brien; Henry J Kaplan; Deming Sun
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-05-01       Impact factor: 4.799

7.  The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cells.

Authors:  Vivian G Oehler; Katherine A Guthrie; Carrie L Cummings; Kathleen Sabo; Brent L Wood; Ted Gooley; Taimei Yang; Mirjam T Epping; Yaping Shou; Era Pogosova-Agadjanyan; Paula Ladne; Derek L Stirewalt; Janis L Abkowitz; Jerald P Radich
Journal:  Blood       Date:  2009-07-22       Impact factor: 22.113

8.  Transforming growth-interacting factor (TGIF) regulates proliferation and differentiation of human myeloid leukemia cells.

Authors:  Rizwan Hamid; Stephen J Brandt
Journal:  Mol Oncol       Date:  2009-07-29       Impact factor: 6.603

9.  Filomicelles Deliver a Chemo-Differentiation Combination of Paclitaxel and Retinoic Acid That Durably Represses Carcinomas in Liver to Prolong Survival.

Authors:  Praful R Nair; Cory Alvey; Xiaoling Jin; Jerome Irianto; Irena Ivanovska; Dennis E Discher
Journal:  Bioconjug Chem       Date:  2018-03-01       Impact factor: 4.774

10.  Divergent interactions of Ehrlichia chaffeensis- and Anaplasma phagocytophilum-infected leukocytes with endothelial cell barriers.

Authors:  Jinho Park; Kyoung-Seong Choi; Dennis J Grab; J Stephen Dumler
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.